Pilot Study: L. acidophilus (TW01) for Gut Health, Body Composition, and Inflammation
This pilot study is looking at how a probiotic called L. acidophilus (strain TW01), which comes from fermented coffee, might affect your gut health, body shape, and inflammation. We're testing if taking capsules with this probiotic, along with a fiber source (Fibersol-2), can make a positive difference. You might be able to join if you are between 18 and 60 years old, are overweight or obese (BMI between 28 and 40), and are otherwise healthy. The main goal is to see if this probiotic changes the amount of a substance called fecal butyrate in your stool. The study status is currently unclear, and it plans to enroll 12 participants.
- Study design
- This is an interventional pilot study, but the specific phase is not mentioned. It will involve 12 participants.
- What's involved
- You would need to consume experimental capsules daily and prepare and eat delivered meal kits. The intervention phases are 6 weeks long.
- Compensation
- Not stated in the trial record.
- Follow-up
- Fecal butyrate will be measured from the beginning to the end of each 6-week intervention phase.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
L. Acidophilus (Strain TW01) on Gut Health, Body Composition, and Inflammation
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Fecal butyrateFrom baseline to the end of each 6-week intervention phase
Determine the effects of the probiotic on the short-chain fatty acid, butyrate (mmol/L), a marker of gut health in stool